Connective Tissue Oncology Society shared a post on LinkedIn:
“We’re proud to share our latest podcast episode with Professor Ian Judson, a true pioneer in sarcoma oncology from the UK.
Across his career at The Royal Marsden Hospital and the Institute of Cancer Research, Prof. Judson has been at the forefront of developing and leading clinical trials that defined standards of care in sarcoma, including studies that shaped how we use doxorubicin, ifosfamide, and other key treatments. His leadership in EORTC, CTOS, and international collaborations has helped to build the global community of sarcoma researchers and clinicians, always with patients at the center.
In this conversation, Prof. Judson reflects on his decades of experience — the challenges of treating ultra-rare cancers, the breakthroughs that gave hope, and the importance of teamwork across borders. For anyone passionate about the history and future of sarcoma treatment, this episode is a must-listen.
You can find our podcasts on multiple streaming platforms, including:
Spotify.
Apple Podcasts.
Amazon Music.”
More Posts Featuring Connective Tissue Oncology Society.